Adverse effect of lomotil therapy in shigellosis.
D000328:Adult; D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use; D001285:Atropine / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003106:Colon / Q000382:microbiology; D003967:Diarrhea / Q000382:microbiology; D004338:Drug Combinations; D004341:Drug Evaluation; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005334:Fever / Q000209:etiology; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects; D007421:Intestine, Small / Q000382:microbiology; D007540:Isonipecotic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D010093:Oxolinic Acid / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D012762:Shigella dysenteriae / Q000302:isolation & purification; D013997:Time Factors
D004338:Drug Combinations; D005765:Gastrointestinal Agents; D007540:Isonipecotic Acids; D010919:Placebos; D001285:Atropine; D000667:Ampicillin; D010093:Oxolinic Acid